Introduction
Norwegian farmed Atlantic salmon (Salmo salar L) have faced major changes in their feed composition during the last decades, changing from a purely marine-based diet in the 1990s to diets containing 70% plant ingredients [1] . As a result, the levels of health-promoting omega-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA) eicosapentaenoic (EPA; 20:5n-3) and docosahexaenoic (DHA; 22:6n-3) acids decreased significantly in salmon organs and tissues [2] . Nevertheless, the lipid composition of an organism is not only affected by ingested lipids, but also by the capacity of organs or tissues to transform these lipids through desaturation and elongation pathways and by the endogenous capacity to synthesize lipids. Vertebrates lack the necessary enzymes to produce n-3 LC-PUFA de novo, and thus
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The aim of the present study was to investigate how EPA, DHA, and lipoic acid (LA) influence the different metabolic steps in the n-3 fatty acid (FA) biosynthetic pathway in hepatocytes from Atlantic salmon fed four dietary levels (0, 0.5, 1.0 and 2.0%) of EPA, DHA or a 1:1 mixture of these FA. The hepatocytes were incubated with [1- 14 C] 18:3n-3 in the presence or absence of LA (0.2 mM). Increased endogenous levels of EPA and/ or DHA and LA exposure both led to similar responses in cells with reduced desaturation and elongation of [1- 14 C] 18:3n-3 to 18:4n-3, 20:4n-3, and EPA, in agreement with reduced expression of the Δ6 desaturase gene involved in the first step of conversion. DHA production, on the other hand, was maintained even in groups with high endogenous levels of DHA, possibly due to a more complex regulation of this last step in the n-3 metabolic pathway. Inhibition of the Δ6 desaturase pathway led to increased direct elongation to 20:3n-3 by both DHA and LA. Possibly the route by 20:3n-3 and then Δ8 desaturation to 20:4n-3, bypassing the first Δ6 desaturase step, can partly explain the maintained or even increased levels of DHA production. LA increased DHA production in the phospholipid fraction of hepatocytes isolated from fish fed 0 and 0.5% EPA and/or DHA, indicating that LA has the potential to further increase the production of this health-beneficial FA in fish fed diets with low levels of EPA and/or DHA. their production is dependent on biosynthesis from essential preformed C 18 PUFA obtained from the diet [3] .
Endogenous production of LC-PUFA differs notably among species, and is determined to a large extend by the repertoire of fatty acyl elongase (Elovl) and desaturase (Fad) enzymes and their substrate specificities [4] . Salmonids, including Atlantic salmon, are able to elongate and desaturate C 18 PUFA to C 20 and C 22 PUFA [5, 6] , and knowledge of the key enzymes involved is available [7] [8] [9] [10] [11] . Both bioactive LC-PUFA arachidonic acid (ARA; 20:4n-6) and EPA are synthesized by the same enzymes, requiring a Δ6 desaturation of 18∶2n-6 and α-linolenic (ALA; 18:3n-3) precursors, respectively, followed by chain elongation and a further Δ5 desaturation. Alternatively, EPA can be produced via elongation of 18:3n-3 to 20:3n-3 followed by Δ8 and Δ5 desaturation [12, 13] . DHA synthesis from EPA requires two further elongations, a Δ6 desaturation and a peroxisomal β-oxidation chain-shortening step [14] . However, a more direct pathway for DHA production from EPA via elongation to 22:5n-3 and Δ4 desaturase has been recently described in several teleost species [15] [16] [17] [18] [19] as well as in humans [20] . There are several factors controlling the n-3 fatty acid (FA) biosynthetic pathway. Although the same desaturases and elongases compete for FA substrates of the n-6 and n-3 families, in general with a preference for n-3 [3] , the dietary FA composition is known to influence enzyme activity. For instance, hepatocytes from Atlantic salmon fed diets with high levels of n-6 FA presented a higher capacity to increase the products of Δ6-desaturase from 18:3n-3 [21, 22] . In addition, the desaturation and elongation of 18:2n-6 and 18:3n-3 have been shown to be markedly enhanced by EFA deficiency [6] .
Lipid-sensing transcription factors such as sterol regulatory element binding protein 1 (SREBP1) play a role in the transcriptional regulation of LC-PUFA biosynthesis in Atlantic salmon [23] . The expression of genes of the LC-PUFA biosynthetic pathway (elovl and fads2) is regulated by SREBP1 in salmon, and the srebp1 gene is transcriptionally activated by diets containing vegetable oils (VO) [23] . VO-based diets have been consistently reported to increase enzymatic activity of desaturases and elongases to produce EPA and DHA from 18:3n-3 [24, 25] . Two explanations have been proposed: no inhibitory effect from dietary LC-PUFA, or a stimulatory effect from high concentrations of C 18 substrates [25] [26] [27] . Despite the stimulatory effect on the enzymes, FO-based feeds result in higher DHA tissue levels than those obtained with VO-diets [2, 28] . Similar results are observed in mammals, in which 18:3n-3 supplementation increases EPA and DHA levels but to a lower degree than that attained with direct use of the preformed n-3 LC-PUFA [29] . Thus, a better understanding of FA bioconversion capabilities would allow improved dietary FA utilization in farmed fish, thereby providing a significant contribution towards more efficient use of marine resources in fish feeds.
Different strategies to optimize the innate capacities for EPA and DHA production from ALA can be used. For example, the FA composition of the diet may be optimized or a bioactive component to stimulate the pathway may be included. Lipoic acid (LA) is a promising bioactive molecule that plays a role in controlling lipid homeostasis [30] . In addition, LA possesses important antioxidant properties [31] . LA was shown to increase the nutritional value of the South American pacu (Piaractus mesopotamicus) by increasing EPA levels in the muscle [32] , indicating a role in the regulation of the n-3 pathway.
In the present study we aimed to test the hypothesis that both optimized diet composition and use of bioactive components such as LA play an important role in modulating the capacity of Atlantic salmon hepatocytes to produce EPA and DHA from 18:3n-3.
Materials and Methods

Chemicals and Reagents
Radiolabeled FA [1- 14 C] 18:3n-3 (50 mCi/mmol) was obtained from American Radiolabeled Chemicals (St. Louis, MO, USA). α-Lipoic acid (racemic form), essential FA-free bovine serum albumin (BSA), fetal bovine serum (FBS), Leibovitz-15 (L-15), 20,70-dichlorfluorescein, 20,70-dichlorfluorescein, collagenase, phosphate buffer saline (PBS), phenylethylamine, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), BHT, sodium bicarbonate solution, l-glutamine, Trypan blue, antibiotics, and total protein kit were obtained from SigmaAldrich (St. Louis, MO, USA). Cell flasks and cell scrapers were obtained from Nalge Nunc International (Rochester, NY, USA). Metacain MS-222 was purchased from Norsk Medisinaldepot (Norway). Perchloric acid (HCIO 4 ), thin-layer chromatography (TLC) plates, and all solvents and other chemicals for FA analysis were purchased from Merck (Darmstadt, Germany). FA peaks were identified by comparison with the standard mixtures GLC-85 and GLC-463 obtained from Nu-chek Prep (Elysian, MN, USA). Ecoscint A scintillation liquid was purchased from National Diagnostics (Atlanta, GA, USA). PureLink Pro 96 RNA Purification Kit and PureLink DNase were obtained from Invitrogen (Carlsbad, CA, USA), TaqMan Reverse Transcription Reagents kit from Applied Biosystems (Foster City, CA, USA), and LightCycler 480 SYBR Green I Master from Roche Applied Science (Mannheim, Germany).
Fish and Feeding
Atlantic salmon with a mean initial weight of 52.8 g were kept in indoor tanks with seawater from smoltification and grown to approximately 400 g at Nofima Research Station in Sunndalsøra, Norway. Fish were fed for 26 weeks on one of ten experimental diets. The experimental diets were isoproteic (46.7%), isolipidic (25.2%), and isoenergetic (22.2 MJ/kg) and were formulated to cover the nutritional requirements for amino acids and minerals according to the National Research Council [33] . The experimental diets selected in the present study were formulated to test four dietary levels of EPA, DHA, or a 1:1 mixture of EPA and DHA (0, 0.5, 1.0, and 2.0% in all dietary groups) ( Table 1 ). The content of 18:3n-3, the precursor of LC-PUFA EPA and DHA, was kept at approximately the same level in all diets (4.7% of total fatty acids and 1.2% of the diet). A detailed description of the experimental conditions and dietary composition is given by Bou et al. [34] . At the end of the experiment, three fish per dietary treatment were anesthetized in a MS-222 solution (0.2 g/L) for 5-10 min prior to isolation of hepatocytes. The average fish weight was 379.7 ± 96.5 g and no major differences in growth between dietary treatments were observed. The experiment was conducted according to the National Guidelines for Animal Care and Welfare published by the Norwegian Ministry of Education and Research (Forsøksdyrforvaltningens tilsynsog søknadssystem (FOTS) approval 5354).
Hepatocytes isolated from Atlantic salmon fed 10 different experimental diets with different levels of EPA and/ or DHA were incubated with radiolabeled 18:3n-3 in the presence and absence of LA. The radiolabeled 18:3n-3 was used to measure changes in FA metabolism, desaturation and β-oxidation. In addition, a parallel experiment was carried out with hepatocytes incubated in the presence or absence of LA to analyze the transcript levels of some lipid related genes. The details of the different methodological and analytical steps are described below.
Isolation of Hepatocytes
Cells were isolated from three fish per dietary condition and one independent culture per fish was performed. Livers were perfused following a modified two-step collagenase procedure [35, 36] and conducted as previously described [37] . After collagenase perfusion, parenchymal cells were isolated by gently shaking the digested liver in L-15 medium. The suspension of parenchymal cells obtained was filtered through a 100-μm mesh nylon filter, washed three times in L-15 medium, sedimented by centrifugation for 2 min at 50×g, and resuspended in L-15 medium containing 10% FBS, 0.9 mM sodium bicarbonate, 2 mM l-glutamine, 1% penicillin-streptomycin solution, 5 hepatocytes/cm 2 were placed in flasks or on six-well plates (25 cm 2 and 9.6 cm 2 / well, respectively), coated with laminin, and left to attach for 16 h at 13 °C. Two cell flasks and two wells from each fish were seeded for the experiments. Furthermore, 1 mL of hepatocyte suspension was used to evaluate the effects of the experimental diets on the FA composition of the hepatocytes.
Incubation of Hepatocytes with Radiolabeled 18:3n-3 and Lipoic Acid
Isolated hepatocytes in flasks were washed with L-15 medium without serum supplementation, and then incubated for 48 h with 21 nmol [1- 14 C] 18:3n-3 (7 μM final concentration) and with or without 0.2 mM LA in a total volume of 3 mL of L-15 medium with 2% FBS. LA dose and incubation time were selected based on previous studies [38] . Radiolabeled FA substrate (1.8 μCi, 50 mCi/ mmol) was added to the medium as a sodium salt bound to FA-free BSA at a molar ratio of FA to BSA of 2.7:1. After incubation, the culture medium was transferred from the culture flasks to vials and centrifuged for 5 min at 50×g. The supernatants (culture media) were immediately frozen at −80 °C and stored for determination of radiolabeled lipids and oxidation products. Hepatocytes supplemented with 18:3n-3 were washed twice in PBS with 1% albumin, once with regular PBS, harvested in 2 mL PBS, and stored at −80 °C until lipid analysis.
Aliquots of 10, 20, 30, 40, and 50 μL of medium containing radioactive 18:3n-3 were transferred before incubation to vials with 8 mL Ecoscint A scintillation liquid to determine total and specific radioactivity (cpm/nmol FA). Samples were counted in a TRI-CARB 1900 TR scintillation counter (Packard Instrument Co., North Chicago, IL, USA).
Lipid Extraction and Analysis
Total lipids were extracted from culture media and cells incubated with radiolabeled 18:3n-3 as previously described [39] . The chloroform phase was dried under nitrogen gas and the residual lipid extract was redissolved in 1 mL chloroform. Fifty μL of chloroform were transferred to vials containing 8 mL scintillation liquid and the remaining volume was used for lipid analysis. Free fatty acids (FFA), phospholipid (PL), monoacylglycerols and diacylglycerols (MDG), and triacylglycerol (TAG) were separated by thin-layer chromatography (TLC) using petroleum ether, diethyl ether, and acetic acid (113:20:2 v/v/v) as the mobile phase. Samples were applied on silica gel TLC plates. Lipids were identified by comparison with known standards using a Bioscan AR-2000 Radio-TLC and Imaging Scanner and quantified with the WinScan Application Version 3.12 (Bioscan Inc., Washington, DC, USA). The esterified FA, PL, and NL fractions within the media will be denoted as secreted FA. Spots corresponding to PL and TAG from the cellular lipids were scraped off into glass tubes and trans-methylated for 16 h with 2,2-dimethoxypropane, methanolic HCl, and benzene at room temperature as previously described [40, 41] .
Total levels of non-labeled lipids were determined by extraction of PL and NL as described above from hepatocytes isolated from three fish in each dietary group. Immediately after isolation, the cells were washed twice in PBS, centrifuged for 2 min at 1000×g, the supernatant was removed, and the cells were stored at −80 °C until lipid analysis. TLC plates containing these samples were sprayed with 0.2% (w/v) 2′,7′-dichlorofluorescein in methanol and viewed under UV light to identify lipids by comparison with known standards.
FA Composition Analysis
The radioactive FA compositions of the PL and NL fractions were determined by reverse-phase HPLC as previously described [42] . The mobile phase contained acetonitrile/H 2 O (85:15 v/v, isocratic elution) and was set to a flow rate of 1 mL/min at 30 °C. A reverse-phase Symmetry 3.5 μm C-18 HPLC column from Waters was used. Radioactive FA levels were measured in an A100 radioactive flow detector (Tri-Carb 1900TR; Packard Instruments). FA were identified by comparing sample and FA standards retention times. Nonradioactive FA standards were detected by absorbance at 215 nm in a UV detector (Waters 2996 PDA Detector).
Unlabeled methyl esters of FA from the PL and NL fractions of hepatocytes were separated in a GC (Hewlett Packard 6890) with a split injector, an SGE BPX70 capillary column (length 60 m, internal diameter 0.25 mm, and film thickness 0.25 μm), a flame ionization detector, and HP Chem Station software. Helium was the carrier gas. The injector and detector temperatures were set to 280 °C. The oven temperature was raised from 50 to 180 °C at a rate of 10 °C/min, and then raised to 240 °C at a rate of 0.7 °C/ min. The relative amount of each FA was expressed as a percentage of the total amount of FA in the analyzed sample and the absolute amount of FA per gram of tissue was calculated using C23:0 methyl ester as internal standard.
Measurement of 14 CO 2 and Acid-Soluble Products from [1-14 C] 18:3n-3
The levels of β-oxidation of 18:3n-3 were measured by counting oxidation products ( 14 C-labeled acid-soluble products (ASP) and 14 CO 2 formed) essentially as previously described [43] . The amount of gaseous [1- 14 C] CO 2 produced during incubation was determined by transferring 1.5 mL of medium to a glass vial which was then sealed. The glass vial contained a central well with a Whatman filter moistened with 0.3 mL of phenylethylamine/methanol (1:1, v/v). The medium was acidified with 0.3 mL 1 M HClO 4 , the samples were incubated for 1 h, and then the wells containing the filters were placed in vials for scintillation counting.
The levels of [1- 14 C] ASP were determined by acidifying 1 mL of the medium with 0.5 mL ice-cold 2 M HClO 4 and incubating the sample for 60 min at 4 °C. The medium was then centrifuged, and an aliquot of the supernatant was collected for scintillation counting.
Protein Content
Protein content of cells was determined using the Total Protein kit (Micro Lowry/Peterson's modification) [44, 45] and absorbance at 540 nm in a Titertek Multiscan 96-well plate reader (Labsystem, Finland).
Total RNA Extraction, cDNA Synthesis, and Real-Time PCR
Isolated hepatocytes in six-well plates were washed with L-15 medium without serum and then incubated for 48 h with or without 0.2 mM LA in 3 mL L-15 medium with 2% FBS. After incubation, the hepatocytes were washed twice in PBS, harvested in 1 mL Trizol, and stored at −80 °C until RNA extraction.
Total RNA was isolated using PureLink Pro 96 RNA Purification Kit according to the manufacturer's instructions. RNA was treated with PureLink DNase to remove any contaminating DNA. RNA concentration was measured using a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). All RNA samples used in our experiments had A260/280 ratios between 2.02 and 2.14. Total RNA (450 ng) was reversetranscribed into cDNA in a 20-µL reaction using the TaqMan ® Reverse Transcription Reagents kit according to the manufacturer's protocol.
PCR primers (Table 2) were designed using the Vector NTI software (Invitrogen, Carlsbad, CA, USA) and synthesized by Invitrogen. The efficiency was checked in ten-fold serial dilutions of cDNA for each primer pair. Real-time PCR was performed in a LightCycler 480 (Roche Applied Science, Germany). The PCR master mix consisted of 1 μL forward and reverse primers (final concentrations of 0.5 μM), 4 μL of a 1:10 dilution of cDNA, and 5 μL LightCycler 480 SYBR Green I Master mix. All samples were analyzed in duplicate with a non-template control (NTC) for each gene. The reaction conditions were 95 °C for 5 min, and 45 cycles of 95 °C for 15 s and 60 °C for 1 min. The specificity of PCR amplification was confirmed by melting curve analysis (95 °C for 5 s, 65 °C for 1 min, and then 97 °C). Rpol2, [46] .
Statistical Analysis
Flasks or wells were used as experimental units (n = 3). Changes in FA composition of the PL and NL fractions of hepatocytes were analyzed by one-way analysis of variance (ANOVA) followed by the Tukey's honest significant difference post hoc test to detect differences within dietary groups. All other data were analyzed by a two-way ANOVA using diet and presence or absence of lipoic acid as effects. Spearman's correlation coefficients were calculated to estimate the association of cellular EPA or DHA and 18:3n-3 with different FA products. Differences were considered statistically significant at P < 0.05. Values are shown as means ± SEM. All statistical analyses were conducted using the software JMP ® version 11.2.1 (SAS Institute Inc., Cary, NC, 1989-2007).
Results
Endogenous FA Composition of Hepatocytes
To test whether FA content of fish was affected by dietary FA, the endogenous FA composition in salmon hepatocytes was determined. The results show that FA content was significantly affected by dietary FA. The n-6/n-3 ratio gradually increased in the PL fraction of hepatocytes of fish fed diets containing less n-3 LC-PUFA (Table 3) , and increasing dietary levels of EPA and/or DHA significantly increased the content of DHA in the PL fraction. In contrast, EPA levels in the PL fraction from fish fed the DHA diets were similar to those from fish fed the 0% diet. Nevertheless, the highest levels of DHA were detected in fish fed a diet with 2.0% DHA. The DHA content in the membranes of the deficient group (0% diet) was reduced threefold when compared to that from the 2.0% DHA dietary group. In contrast, fish fed the 0% diet almost doubled the amount of n-6 FA compared to that of fish fed the 2.0% diets (2.0% EPA, 2.0% DHA, and 2.0% EPA + DHA diets). This increase in n-6 FA content was mainly due to increased levels of 20:4n-6 and 20:3n-6, followed by 18:2n-6. This was reflected on the n-6 desaturation index, with the highest value corresponding to hepatocytes isolated from fish fed the 0% diet and gradually decreasing as the dietary n-3 LC-PUFA were increased. The FA composition of the NL fraction was less affected by dietary lipid (Table 3) , although the amount of PUFA gradually decreased in the NL fraction of hepatocytes as the fish received diets containing less n-3 LC-PUFA. This decrease in PUFA was followed by an increase in MUFA, mainly 18:1n-9. The amount of PUFA was less abundant in the NL than in the PL fraction, whereas the amount of MUFA was more abundant in the NL than in the PL fraction. The levels of the 18:3n-3 precursor remained unaltered regardless of dietary treatment in both fractions. The relative lipid class distribution between total PL and NL fractions, determined using an internal standard GC approach, was not altered by dietary treatment, with the majority being in the PL form and representing ~75%.
Effect of Endogenous FA Composition and LA Supplementation on the Metabolism of [1-14 C] 18:3n-3
To study the dietary and LA effects on the uptake and metabolism of 18:3n-3, Atlantic salmon hepatocytes isolated from fish fed 10 different diets containing different levels of EPA and/or DHA were incubated with [1- 14 C] 18:3n-3 in the presence or absence of LA for 48 h. Table 4 shows the total uptake and radioactivity distribution from 18:3n-3 recovered in cellular lipids, water-soluble oxidation (ASP + CO 2 ) products, and secreted lipids in the culture media. The majority of 18:3n-3 was taken up by hepatocytes and incorporated into cellular lipids (12.4 ± 0.17 nmol, corresponding to 59.2% of added substrate). The level of incorporation into cellular lipids did not differ between LA-supplemented and control cells. In contrast, the endogenous FA composition had a significant effect on cellular incorporation of radiolabeled FA, with the 0% dietary group presenting the highest incorporation (13.7 ± 0.26 nmol; average value between control and LAsupplemented cells). The level of radiolabeled secreted lipids did not differ between LA-supplemented and control cells. Nevertheless, the TAG secretion average in control cells was 1.48 ± 0.51 nmol while that from LA-supplemented cells was 1.03 ± 0.50 nmol (data not shown). LA addition promoted the formation of ASP but decreased the production of CO 2 from 18:3n-3. In addition, the amount of ASP was higher in hepatocytes isolated from fish fed diets containing 1.0 and 2.0% n-3 LC-PUFA (EPA and/or DHA) than in the other dietary groups. Table 5 shows the relative distribution of esterified radiolabeled lipids derived from [1- 14 C] 18:3n-3. The majority of radiolabeled FA was found in PL, in which an average of 86 and 76% of radiolabeled substrate was incorporated in control and LA-supplemented hepatocytes, respectively. Close to 12 and 21% of radiolabeled substrate was used for TAG production in hepatocytes incubated in control or LA-supplemented medium, respectively on average. Only a minor part of radiolabeled 18:3n-3 was used for MDG (2%) n-6/n-3 and cholesteryl esters (CE) (0.4%) production in all conditions studied; non-esterified free FA were below the detection threshold. In general, a gradual increase in the relative production of TAG and a concomitant decrease in PL was found in hepatocytes isolated from fish fed with increasing levels of EPA and/or DHA. On the other hand, LA consistently decreased the relative production of PL and favored that of all the other NL analyzed.
Effect of Endogenous FA Composition and LA Supplementation on the Desaturation and Chain-Elongation of [1-14 C] 18:3n-3
The main products of 18:3n-3 in the PL fraction were EPA and DHA, followed by 20:4n-3 and 20:3n-3 ( Table 6 ). The PL fraction of hepatocytes isolated from fish fed the 0% diet presented the highest content of 18:3n-3 regardless of being cultivated in the presence or absence of LA. A gradual decrease in 18:3n-3, 18:4n-3, 20:4n-3, EPA, and 22:5n-3 content was observed in the PL fraction of hepatocytes isolated from fish fed with increasing levels of EPA and/or DHA, while that of 20:3n-3 gradually increased. LA supplementation in the medium affected 18:3n-3 metabolism (Fig. 1a) in a similar fashion as resulting from increasing the dietary content of n-3 LC-PUFA (Fig. 2a) . Thus, LA further reduced the levels of 18:3n-3, 18:4n-3, 20:4n-3, EPA, and 22:5n-3 in the PL fraction of hepatocytes, whereas it increased 20:3n-3 levels. Surprisingly, endogenous FA composition had no significant effect on the production of DHA. A slightly higher production was observed in cells from fish fed with the highest levels of n-3 LC-PUFA. However, a significant interaction between LA and diet was observed in which LA only promoted the presence of DHA in the PL fraction of hepatocytes from fish fed 0 and 0.5% EPA and/or DHA. Interestingly, the DHA contents in the PL fraction of hepatocytes from fish fed 0.5% EPA, 0.5% DHA, and 0.5% EPA + DHA diets were fairly similar (19.7 ± 0.52 mol %; average value of the aforementioned diets), indicating that endogenous DHA content may be the factor modulating the effects of LA. The main product from 18:3n-3 found in the NL fraction was 20:3n-3, but smaller amounts of DHA, EPA, and 18:4n-3 were also produced (Table 7) . However, the production of 18:4n-3 and EPA was not affected by endogenous FA composition or by LA addition. A gradual increase in the deposition of 18:3n-3, 20:3n-3, and DHA contents in the NL fraction of hepatocytes isolated from fish fed with increasing dietary levels of EPA and/or DHA or supplemented with LA was observed. On the other hand, 20:4n-3 and 22:5n-3 levels were below the detection threshold in several experimental groups. LA supplementation and dietary n-3 LC-PUFA had similar effects on the picomoles recovered in 18:3n-3 and its products in the NL fraction (Figs. 1b, 2b ). The total DHA production represented as the sum of recovered picomoles in PL and NL showed that LA supplementation increased DHA production in hepatocytes isolated from fish fed ≤0.5% EPA and/or DHA (Fig. 3) .
To determine the association strength between cellular EPA or DHA and the desaturation and elongation of 18:3n-3 substrate to its different FA products, Spearman's correlation coefficients were calculated (Table 8 ). DHA cellular content had a stronger association with all FA produced compared to that from EPA cellular content.
Effect of Endogenous FA Composition and LA Supplementation on the Transcriptional Regulation of the n-3 Biosynthetic Pathway
Because differences in 18:3n-3 desaturation and elongation were observed in hepatocytes isolated from fish fed with different levels of EPA and/or DHA cultivated in LA-free or LA-supplemented medium, we further investigated whether these differences were associated with changes in transcript abundance of genes encoding proteins related to lipid metabolism. Transcript levels of genes coding for srebp1, aco, elovl2, elovl5b, Δ5fad, and Δ6fad_a are shown in Fig. 4 . Transcript levels of all evaluated genes changed as a result of diet composition and, consequently, of endogenous FA composition. mRNA levels of srebp1 and aco decreased in all dietary groups compared to those of the 0% diet group, whereas Δ5fad mRNA levels increased. Δ6fad_a, elovl2, and elovl5b gene transcripts were modulated in a dose-dependent manner, with decreasing levels as n-3 LC-PUFA levels increased. LA addition only increased gene transcript levels of the two elongases assessed.
Discussion
One of the main aims of the study was to investigate the effects of different dietary levels of EPA and/or DHA on the fish 18:3n-3 metabolism. The endogenous FA composition of hepatocytes was influenced by dietary FA composition. These results are in agreement with several studies in salmonids where different lipid sources were tested [5, 25, 37, 47, 48] . In general, increasing levels of dietary EPA increased cellular levels of EPA, 22:5n-3, and DHA, whereas increasing DHA dietary levels only increased cellular DHA content. In addition, decreasing dietary n-3 levels increased the levels of 20:3n-6 and 20:4n-6 in the PL fraction of hepatocytes, showing a stimulation of the n-6 pathway by 18:2n-6 when EPA and DHA are lacking. It has been extensively reported that feeding fish with a VO-based diet leads to increased activity of the n-6 and n-3 biosynthetic pathways [2, 24, 25, 49, 50] . Two main explanations have been proposed for the stimulation of the pathway: an increase in C 18 substrate availability, and a lack of C 20 and C 22 PUFA. However, determining Table 5 Percentage distribution between phospholipids (PL), monoand diacylglycerol (MDG), triglycerides (TAG), and cholesteryl esters (CE) produced from [1- which of these two factors might have a bigger effect is not trivial, because so far the practical diets tested with high levels of n-3 LC-PUFA had low levels of C 18 PUFA and vice versa. In the present study, the dietary levels of 18:3n-3 were kept constant at 1.2 ± 0.02% in all tested diets. In addition, the levels of 18:2n-6 were kept stable at 5.4 ± 0.08%, providing a steady 18:2n-6/18:3n-3 ratio of 4.5. These conditions allowed us to rule out a possible effect caused by competition between both substrates for the enzymes and to relate changes in the endogenous n-3 biosynthetic pathway activity directly to dietary and cellular n-3 LC-PUFA content. Hepatocytes isolated from fish fed with increasing levels of n-3 LC-PUFA showed a significant decrease in the production of radiolabeled 20:4n-3, EPA, and 22:5n-3 in the PL fraction, and the production of these FA was further reduced in cells supplemented with LA. These results are in agreement with previous studies showing a reduction in the FA biosynthetic pathway linked to LC-PUFA availability [25, 26] . Strikingly, neither diet nor LA supplement had any effect on the levels of radiolabeled esterified DHA in the PL fraction. However, these two factors interacted, and thus LA exposure led to increased elongation and desaturation of 18:3n-3 to DHA in hepatocytes from fish fed diets containing 0 and 0.5% EPA and/or DHA. In contrast, LA exposure of cells from fish fed with higher dietary levels of EPA and/or DHA resulted in a reduced cellular capacity to transform 18:3n-3 into DHA. It is noteworthy that the endogenous DHA contents in the PL fractions of fish fed 0.5% EPA, 0.5% DHA, and 0.5% EPA + DHA were fairly similar (19.7 ± 0.52 mol%), suggesting that cellular DHA may be modulating the effects of LA. In a recent study, dietary LA supplementation also increased the DHA content in the liver of diet-induced nonalcoholic fatty liver disease mice [51] . Despite the observed stimulation of DHA synthesis by LA, it had no effect on the transcriptional regulation of desaturase genes. Incubation of salmon hepatocytes with sesamine, another bioactive component, was reported to also increase the conversion of 18:3n-3 to DHA but, paradoxically, decrease Δ5fad and Δ6fad gene transcripts [52] . On the other hand, the NL fraction of hepatocytes isolated from fish fed with increasing levels of n-3 LC-PUFA showed a significant increase in DHA production that was further increased by LA addition. However, this LA-induced increase did not compensate for the aforementioned decrease in DHA production in the PL fraction of hepatocytes isolated from fish fed diets containing EPA and/or DHA at dietary levels of 1.0% or above.
In the n-3 FA pathway, 18:3n-3 can either be desaturated via Δ6 desaturase to 18:4n-3 or elongated via Elovl5 to 20:3n-3. Desaturation was favored by low dietary levels of n-3 LC-PUFA in the PL fraction of hepatocytes, whereas the addition of LA had no effect in the production of 18:4n-3. In contrast, elongation of 18:3n-3 to 20:3n-3 was promoted in both lipid fractions by increasing dietary levels of n-3 LC-PUFA and by LA addition. This is in agreement with previous studies showing that hepatocytes isolated from Atlantic salmon fed FO-based diet rich in n-3 LC-PUFA [48] , supplemented with DHA in the culture medium [5] , or supplemented with LA [38] , significantly enhanced the production of 20:3n-3. Furthermore, the cellular DHA content in control cells was strongly correlated (0.883; P < 0.0001) to the amount of 20:3n-3. This FA was considered to be a dead-end product of the pathway. However, it was recently shown that not only mammalian [13] , but also teleostei, Δ6 Fads possess Δ8 desaturase activity [12] , and thus 20:3n-3 can be desaturated to 20:4n-3, which can then be reincorporated into the pathway for further Δ5 desaturation. Even though the activity of the Δ8 pathway in freshwater/diadromous species has been reported to be low compared to that from other marine teleosts [12] , it might provide an alternative route for the synthesis of EPA from 18:3n-3 that does not involve a Δ6 desaturation. As suggested by the correlation coefficients in our study, cellular DHA content seems to have a major effect modulating the activity of the pathway by regulating the conversion of 18:3n-3 to either 20:3n-3 or 18:4n-3. The decrease in content of the desaturation product 18:4n-3 with increasing dietary n-3 LC-PUFA is also consistent with the decrease in Δ6fad_a transcript abundance. However, the n-3 LC-PUFA dietary stimulation of 20:3n-3 production was not accompanied by an up-regulation of elovl5b transcripts in the present study. LA supplementation, on the contrary, increased both elovl5b transcript abundance and 20:3n-3 production. A recent study suggested that land-locked salmon, which remain in freshwater their whole life and thus are naturally surrounded by lower levels of n-3 PUFA, might have a higher Δ8 activity compared to their farmed counterparts [53] . In the present study, radioactivity recovered in 20:4n-3 was significantly reduced in the PL fraction of cells by increasing levels of n-3 LC-PUFA, and the addition of LA reduced it further. Since radioactivity in 20:4n-3 could be the result of either Δ6 or Δ8 activity, it is difficult to draw conclusions. Knowledge of Δ8 activity regulation is still limited, and thus the Δ8 desaturase activity of salmon Δ6fad_a or how diet interacts with this alternative pathway remain to be explored, emphasizing the need for further research. In control cells, despite the decrease in 20:4n-3, EPA, and Δ6fad_a mRNA levels with increasing dietary n-3 LC-PUFA, an increase in radiolabeled DHA was observed. Therefore, it is possible that inhibition of Δ6 activity is compensated by Δ8 or Δ4 activity to provide DHA. A functional Δ4fads was first identified in several teleost species [15] [16] [17] [18] , and recently it has also been characterized in human cancer cells [20] . However, if this desaturation step is of importance in non-cancer human cells is currently unknown. In addition, whether Atlantic salmon possess this ability, and if so, what is the capacity of this direct pathway remain to be explored. Dietary PUFA play a role as ligands of key transcription factors, including SREBP1 [23] . The transcript levels of this transcription factor gene were decreased by dietary n-3 LC-PUFA. These results are in agreement with the regulation described in mammals, in which SREBP1 is activated by low levels of cholesterol and is inhibited by high levels of PUFA [54] . After entering the cell, radiolabeled FA substrate can be used for energy purposes by going through β-oxidation and extensive carbon recycling, or can be esterified into cellular lipids. In the present study, radiolabeled 18:3n-3 or its FA products were preferentially incorporated into PL with increasing percentages found in hepatocytes isolated from fish fed with decreasing levels of n-3 LC-PUFA, and that consequently contained significantly lower amounts of these FA. In contrast, little radioactivity was recovered in TAG, with increasing percentages observed in hepatocytes isolated from fish fed with increasing levels of n-3 LC-PUFA. These results are in agreement with several previous studies in salmonid hepatocytes and muscle cells showing that PUFA are predominately incorporated into PL [47, 55, 56] . In contrast, another study showed that radioactivity was mostly recovered in salmon hepatocytes in the form of TAG [48] . However, in this last study, hepatocytes in suspension were incubated with radiolabeled FA for only 2 h, which may explain the discrepancy in the results.
In this study, we also demonstrated clear effects of LA supplementation on FA metabolism in Atlantic salmon hepatocytes. Even though the amount of radiolabeled cellular lipids was not influenced by LA supplementation, LA significantly reduced the esterification of 18:3n-3 and its products into PL and increased the content of these compounds in storage depots. In addition, this increased 4 Relative changes in mRNA transcript abundance of genes involved in the n-3 fatty acid biosynthetic pathway. Atlantic salmon hepatocytes cultivated in the presence or absence of lipoic acid were isolated from fish fed ten experimental diets containing different levels of EPA and/or DHA for 26 weeks. Samples (n = 3) were analyzed using real-time qPCR and data are presented as −ΔΔCt ± SEM. Cells isolated from fish fed the 0% diet were used as control and values were set to zero. Results are compared by two-way analysis of variance (diet and lipoic acid as factors; P < 0.05) incorporation into cellular TAG was paralleled by a decrease in TAG secretion to the media. In mammals, even though the exact mechanisms are still unclear, strong evidence supports the effects of LA on TAG metabolism [57] . Reduced levels of esterified radiolabelled TAG in the media indicate that LA reduce the secretion of TAG-rich VLDL from hepatocytes to blood, in agreement with the majority of the studies in mammals [57] [58] [59] . Formation of ASP oxidation products was generally enhanced in hepatocytes with the highest endogenous level of DHA, whereas no dietary modulation of CO 2 production was observed. LA supplementation, on the other hand, significantly increased ASP and decreased CO 2 production. LA has been shown to decrease lipid accumulation in non-adipose tissues by stimulating hepatic β-oxidation in mice [60] and in rat skeletal muscle [61] . On the other hand, LA inhibited the oxidation of FFA in primary rat hepatocytes and increased pyruvate oxidation [62] . Because in our experiments LA significantly increased the production of ASP, we speculate that LA may increase DHA production by stimulating peroxisomal β-oxidation [56] . However, the gene transcript abundance of acyl-CoA oxidase (aco), the rate-limiting enzyme of peroxisomal β-oxidation, decreased by n-3 LC-PUFA, whereas addition of LA did not have any effect on its regulation. Lack of regulation of this enzyme by FA at both protein and transcript levels has been reported in rainbow trout hepatocytes [47] and Atlantic salmon hepatocytes [52] , despite showing an increased production of β-oxidation products.
This study indicates that LA plays a role influencing n-3 FA metabolism in Atlantic salmon hepatocytes by enhancing the production of DHA, but this production is restricted by high cellular DHA content. In addition, increasing dietary levels of EPA and/or DHA reduced salmon's innate production of 18:4n-3, 20:4n-3, EPA, and 22:5n-3, but DHA production was maintained, even showing a slight increase with high dietary EPA and/or DHA. To determine the exact mechanisms by which LA and dietary n-3 LC-PUFA increase the levels of health-beneficial LC-PUFA, further research on the Δ6, Δ8, and Δ4 activities is required.
